"LHL-sykehuset Gardermoen er et pasientvennlig, hyggelig og varmt sykehus der pasienter og pårørende lett finner frem, og lett finner seg til rette. LHL-sykehuset eies og driftes av pasientorganisasjonen LHL, som har 30 års erfaring innen sykehusdrift og rehabilitering. Å få behandling i en rolig og lun atmosfære skal oppleves harmonisk, behagelig og helsefremmende. Hos oss skal høy faglig standard og medisinsk kvalitet prege alle tjenester. Vi utreder, behandler, rehabiliterer og følger opp pasienter med mange ulike behov. Vårt mål er at du som pasient skal være tilfreds og føle deg godt ivaretatt."

During the past decade, Feiringklinikken AS conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Feiringklinikken AS" are "Coronary Arteriosclerosis" (1 trials), "Coronary Artery Disease" (1 trials), "Coronary Artery Restenosis" (1 trials), "Coronary Artery Stenosis" (1 trials) and "Coronary Heart Failure" (1 trials). Many other conditions were trialed in "Feiringklinikken AS" in a lesser frequency.

Most popular intervention types in "Feiringklinikken AS" are "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "The GPS™ II Platelet Concentrate Separation Kit" (1 trials) and "XIENCE V®/ XIENCE PRIME™" (1 trials). Other intervention names were less common.

The vast majority of trials in "Feiringklinikken AS" are 1 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Feiringklinikken AS". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Feiringklinikken AS, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Feiringklinikken AS, 1 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".